Indokem [INDOKEM] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Indokem Ltd. wins in 7 metrics, Neogen Chemicals Ltd. wins in 11 metrics, with 0 ties. Neogen Chemicals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Indokem Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 269.69 222.22 Neogen Chemicals Ltd.
Price-to-Book Ratio 22.50 5.46 Neogen Chemicals Ltd.
Debt-to-Equity Ratio 36.47 141.47 Indokem Ltd.
PEG Ratio -6.37 -3.52 Neogen Chemicals Ltd.
EV/EBITDA 168.32 42.55 Neogen Chemicals Ltd.
Profit Margin (TTM) 2.99% 2.41% Indokem Ltd.
Operating Margin (TTM) -1.00% 11.39% Neogen Chemicals Ltd.
EBITDA Margin (TTM) N/A 11.39% N/A
Return on Equity 5.13% 4.41% Indokem Ltd.
Return on Assets (TTM) 2.25% 1.99% Indokem Ltd.
Free Cash Flow (TTM) $40.10M $-1.22B Indokem Ltd.
Dividend Yield N/A 0.19% N/A
1-Year Return 214.02% 10.59% Indokem Ltd.
Price-to-Sales Ratio (TTM) 8.14 5.56 Neogen Chemicals Ltd.
Enterprise Value $13.75B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 7.71 6.55 Neogen Chemicals Ltd.
Gross Profit Margin (TTM) 34.67% 47.11% Neogen Chemicals Ltd.
Revenue per Share (TTM) $63 $310 Neogen Chemicals Ltd.
Earnings per Share (Diluted) $1.93 $7.47 Neogen Chemicals Ltd.
Beta (Stock Volatility) 0.18 0.22 Indokem Ltd.

Indokem Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Indokem Ltd.-3.04%-9.39%-17.16%7.14%-32.59%-15.84%
Neogen Chemicals Ltd.1.29%5.78%11.27%35.92%70.61%59.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Indokem Ltd.214.02%457.38%1,686.52%10,316.07%13,465.12%9,803.23%
Neogen Chemicals Ltd.10.59%19.04%106.75%609.06%609.06%609.06%

Performance & Financial Health Analysis: Indokem Ltd. vs Neogen Chemicals Ltd.

MetricINDOKEMNEOGEN
Market Information
Market Cap i₹14.52B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,340170,744
90 Day Avg. Volume i5,177127,390
Last Close₹536.70₹1,901.20
52 Week Range₹186.00 - ₹930.00₹966.70 - ₹1,960.30
% from 52W High-42.29%-3.01%
All-Time High₹930.00 (Nov 13, 2025)₹2,420.00 (Dec 09, 2024)
% from All-Time High-42.29%-21.44%
Growth Metrics
Quarterly Revenue Growth-0.03%0.09%
Quarterly Earnings Growth-0.45%-0.63%
Financial Health
Profit Margin (TTM) i0.03%0.02%
Operating Margin (TTM) i-0.01%0.11%
Return on Equity (TTM) i0.05%0.04%
Debt to Equity (MRQ) i36.47141.47
Cash & Liquidity
Book Value per Share (MRQ)₹23.14₹303.78
Cash per Share (MRQ)₹1.08₹57.58
Operating Cash Flow (TTM) i₹-68,900,000₹645.50M
Levered Free Cash Flow (TTM) i₹31.70M₹348.30M
Dividends
Last 12-Month Dividend Yield iN/A0.19%
Last 12-Month Dividend iN/A₹3.00

Valuation & Enterprise Metrics Analysis: Indokem Ltd. vs Neogen Chemicals Ltd.

MetricINDOKEM (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i269.69222.22
Forward P/E iN/A72.26
PEG Ratio i-6.37-3.52
Price to Sales (TTM) i8.145.56
Price to Book (MRQ) i22.505.46
Market Capitalization
Market Capitalization i₹14.52B₹44.76B
Enterprise Value i₹13.75B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i7.716.55
Enterprise to EBITDA i168.3242.55
Risk & Other Metrics
Beta i0.180.22
Book Value per Share (MRQ) i₹23.14₹303.78

Financial Statements Comparison: Indokem Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINDOKEM (2025)NEOGEN (2025)
Revenue/Sales i1.77B7.58B
Cost of Goods Sold i1.22B4.44B
COGS % of Revenue i68.7%58.6%
Gross Profit i554.90M3.13B
Gross Margin i31.3%41.4%
Research & Development iN/A11.50M
Operating Income (EBIT) i60.50M1.09B
Operating Margin i3.4%14.4%
EBITDA i89.90M1.31B
EBITDA Margin i5.1%17.3%
Pre-Tax Income i32.90M501.60M
Pre-Tax Income % of Revenue i1.9%6.6%
Income Tax i1.50M153.30M
Income Tax % of Revenue i0.1%2.0%
Net Income (Profit) i31.40M348.30M
Profit Margin i1.8%4.6%

Balance Sheet & Liquidity Metrics

MetricINDOKEM (2025)NEOGEN (2025)
Cash & Equivalents i30.10M49.60M
Total Current Assets i745.60M10.00B
Total Current Assets % of Revenue i42.0%132.0%
Total Current Liabilities i597.70M7.33B
Total Current Liabilities % of Revenue i33.7%96.8%
Long-Term Debt i119.20M1.94B
Long-Term Debt % of Revenue i6.7%25.6%
Total Shareholders Equity i618.40M7.89B
Retained Earnings i-121.90M2.28B
Retained Earnings % of Revenue i-6.9%30.1%
Property, Plant & Equipment i2.70M890.30M

Cash Flow Statement Comparison

MetricINDOKEM (2025)NEOGEN (2025)
Operating Cash Flow i-68.90M645.50M
Operating Cash Flow % of Revenue i-3.9%8.5%
Capital Expenditures i-10.00M-3.17B
Free Cash Flow i40.10M-1.22B
FCF Margin i2.3%-16.1%
Debt Repayment i-33.20M-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINDOKEMNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i27.89M27.38M
Float Shares i7.78M13.28M
% Held by Insiders i71.54%53.98%
% Held by Institutions i0.00%23.81%
% Held by Public i28.46%22.21%

Dividend Analysis & Yield Comparison: Indokem Ltd. vs Neogen Chemicals Ltd.

MetricINDOKEMNEOGEN
Last 12-Month Dividend iN/A₹3.00
Last 12-Month Dividend Yield iN/A0.19%
3-Year Avg Annual Dividend iN/A₹2.00
3-Year Avg Dividend Yield iN/A0.11%
3-Year Total Dividends iN/A₹6.00
Ex-Dividend DateN/ASep 19, 2025